Geopolitical Risks Refocus Market on Undervalued Bio Gems...Woojung Bio·Geninus Surge[K-Bio Puls... 유진희 2026.03.09 오전 08:00 Investment Sentiment Shifts to Mid Risk...High Return Bio Stocks: Samyang Biopharm and U2Bio Surg... 유진희 2026.01.15 오전 08:10 Cellbion Reports Positive Phase 2 Results in Prostate Cancer Therapy 유진희 2025.09.04 오후 06:00 Hyundai Bioscience Nears Launch of Phase 2·3 Dengue Trial...High Ranking Vietnamese Officials Ga... 유진희 2026.03.05 오후 12:00 Unsolved Hair Loss Seeking a Breakthrough?...FromBio and Hyundai Pharm Surge [K-Bio Pulse] 유진희 2026.01.19 오전 08:00 License-out buzz lifts STCube, Ildong Holdings, Toolgen[K-Bio Pulse] 유진희 2025.11.07 오전 10:37 Biopharma Earnings Drive Undervalued Stocks Higher, L&C Bio Extends Rally[K-Bio Pulse] 유진희 2025.09.09 오전 09:30 Sellbion CEO Kwon Kim: “Maximizing the Power of 177Lu-DGUL Immuno-Oncology Combo” 유진희 2025.07.21 오전 09:30 Cellbion’s radiotherapy shows 35% ORR, looks to expand Merck ties 유진희 2025.09.05 오전 08:30 Wonik Soars on Policy Tailwinds; Y2Solution Gains on Licensing Buzz[K-Bio Pulse] 유진희 2025.06.05 오전 09:10 더 보기 로딩중..